Omega-3 supplement aims to raise key blood fats for heart and brain health

NCT ID NCT07753174

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This 12-week trial is testing whether a daily omega-3 supplement, called Omega Active, can increase blood levels of DHA and EPA—two fatty acids linked to heart and cognitive health. Healthy adults aged 18-65 will take two capsules daily and provide blood samples at the start and end of the study. Participants will also report any changes in their thinking, digestion, and overall well-being through questionnaires. The study aims to see if the supplement can effectively raise these important fats in the body.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Omega Active supplement (omega-3 fatty acids)
What this could lead to
If successful, this could support the use of omega-3 supplements to improve blood levels of DHA and EPA, which are important for heart and brain health.
What could go wrong
This is a small, single-arm study without a placebo group, so results may not prove cause and effect. Also, self-reported outcomes are subjective and may not reflect objective benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    RECRUITING

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.